Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?

被引：0
|
作者：
Rosemarie D. L. C. Bernabe
Ghislaine J. M. W. van Thiel
Nancy S. Breekveldt
Christine C. Gispen
Johannes J. M. van Delden
机构：
[1] University of South-Eastern Norway,Faculty of Health and Social Sciences
[2] University of Oslo,Centre for Medical Ethics, Institute of Health and Society
[3] University Medical Center Utrecht,Julius Center for Health Sciences and Primary Care
[4] Dutch Medicines Evaluation Board,undefined
来源：
BMC Medical Ethics | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 4 条
  • [1] Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?
    Bernabe, Rosemarie D. L. C.
    van Thiel, Ghislaine J. M. W.
    Breekveldt, Nancy S.
    Gispen, Christine C.
    van Delden, Johannes J. M.
    BMC MEDICAL ETHICS, 2020, 21 (01)
  • [2] PRE-MARKETING AUTHORIZATION OF NEW MEDICAL DEVICES IN THE EUROPEAN UNION AND THE UNITED STATES
    Abraham, P. S.
    Gholmie, J.
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    VALUE IN HEALTH, 2013, 16 (03) : A267 - A267
  • [3] Registration, authorization, renewal of pesticides; how the system works in EU and what it offers to the post marketing risk assessment at the workplace
    Moretto, A.
    TOXICOLOGY LETTERS, 2023, 384 : S14 - S15
  • [4] Clinical characteristics and therapeutics sequences of KRAS G12C metastatic non-small cell lung cancer (mNCSLC) patients treated by sotorasib in the French pre-marketing authorization (MA) early access program (cohort temporary authorization of use, cATU)
    Lena, H.
    Cadranel, J.
    Girard, N.
    Mazieres, J.
    Curcio, H.
    Gille, R.
    Flandin, A-C. Madroszyk
    Auliac, J. B.
    Bylicki, O.
    Rieux, C.
    Couraud, S.
    Barlesi, F.
    Pichon, E.
    Metivier, A-C.
    Almotlak, H.
    Pabst, L.
    Deldycke, C.
    Duchemann, B.
    De Gunten, L.
    Quantin, X.
    ANNALS OF ONCOLOGY, 2023, 34
1